Delaware
|
061034587
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
Number)
|
Large
accelerated filer ¨
|
Accelerated
filer ¨
|
Non-accelerated
filer ¨
|
Smaller
reporting company x
|
Page No.
|
||
PART
I - FINANCIAL INFORMATION
|
||
Item
1. Financial Statements
|
F-1
|
|
Condensed
Consolidated Balance Sheets - March 31, 2009 (Restated) (Unaudited) and
December 31, 2008
|
F-1
|
|
Condensed Consolidated Statements
of Operations (Restated) (Unaudited) - Three Months Ended March 31, 2009
and 2008
|
F-2
|
|
Condensed Consolidated Statements
of Cash Flows (Restated) (Unaudited) - Three Months Ended March 31, 2009
and 2008
|
F-3
|
|
Notes
to Condensed Consolidated Financial Statements
|
F-4
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
3
|
|
Item
3. Quantitative and Qualitative Disclosures About Market
Risk
|
7
|
|
Item
4T. Controls and Procedures
|
7
|
|
PART
II - OTHER INFORMATION
|
||
Item
1. Legal Proceedings
|
9
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
9
|
|
Item
3. Defaults Upon Senior Securities
|
9
|
|
Item
4. Submission of Matters to a Vote of Security
Holders
|
9
|
|
Item
5. Other Information
|
9
|
|
Item
6. Exhibits
|
9
|
|
SIGNATURES
|
10
|
(Unaudited)
|
||||||||
March
31,
|
December
31,
|
|||||||
2009
|
2008
|
|||||||
(Restated
- See
Note
6)
|
||||||||
ASSETS
|
||||||||
Current
Assets
|
||||||||
Cash
|
$ | 268,095 | $ | 31,889 | ||||
Contract
receivables, net of allowance of $0 and $24,000 for March 31, 2009 and
December 31, 2008, respectively
|
334,391 | 237,787 | ||||||
Inventories
|
412,889 | 564,022 | ||||||
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
102,028 | 416,664 | ||||||
Deferred
financing costs
|
370,933 | 252,305 | ||||||
Prepaid
expenses and other current assets
|
165,933 | 168,668 | ||||||
Total
current assets
|
1,654,269 | 1,671,335 | ||||||
Property
and Equipment, net
|
172,876 | 186,906 | ||||||
Deferred
Financing Costs, net
|
173,803 | 233,702 | ||||||
Total
Assets
|
$ | 2,000,948 | $ | 2,091,943 | ||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||||||
Current
Liabilities
|
||||||||
Bank
overdraft
|
$ | 32,152 | $ | 15,329 | ||||
Accounts
payable and accrued liabilities
|
1,519,171 | 1,417,464 | ||||||
Dividends
payable
|
459,275 | 459,275 | ||||||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
607,061 | 1,388,348 | ||||||
Capital
lease obligation, current portion
|
28,542 | 27,874 | ||||||
Derivative
liability
|
4,306,028 | 1,975,298 | ||||||
CAMOFI
Convertible note payable, net of discount of $1,756,612 at March 31, 2009
and $2,089,443 at December 31, 2008, respectively
|
1,070,670 | 737,838 | ||||||
CAMHZN
Convertible note payable, net of discount of $294,813 at March 31, 2009
and $350,090 at December 31, 2008, respectively
|
455,187 | 399,910 | ||||||
CAMOFI
Convertible Note, net of discount of $288,039
|
413,161 | - | ||||||
CAMHZN
Convertible Note, net of discount of $71,778
|
102,022 | - | ||||||
Total
current liabilities
|
8,993,269 | 6,421,336 | ||||||
Long
Term Liabilities
|
||||||||
Capital
lease obligation, long term portion
|
2,482 | 9,804 | ||||||
Total liabilities
|
8,995,751 | 6,431,140 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders'
Deficit
|
||||||||
Cumulative,
convertible, Series B preferred stock, $1 par value, 15,000,000 shares
authorized, no shares issued and outstanding (liquidation preference of
$25 per share)
|
- | - | ||||||
Cumulative,
convertible, Series C preferred stock, $1 par value, 75,000 shares
authorized, 26,880 shares issued and outstanding (liquidation preference
of $672,000)
|
26,880 | 26,880 | ||||||
Cumulative,
convertible, Series D preferred stock, $25 par value, 75,000 shares
authorized, 11,640 shares issued and outstanding (liquidation preference
of $291,000)
|
291,000 | 291,000 | ||||||
Common
stock, $0.10 par value, 50,000,000 shares authorized;
15,344,654 shares issued and outstanding at March 31, 2009 and
December 31, 2008
|
1,534,466 | 1,534,466 | ||||||
Notes
receivable from stockholders
|
(564,928 | ) | (564,928 | ) | ||||
Deferred
equity compensation
|
(81,667 | ) | (101,667 | ) | ||||
Additional
paid-in capital
|
7,355,007 | 7,355,007 | ||||||
Accumulated
deficit
|
(15,555,561 | ) | (12,879,955 | ) | ||||
Total
stockholders' deficit
|
(6,994,803 | ) | (4,339,197 | ) | ||||
Total
Liabilities and Stockholders' deficit
|
$ | 2,000,948 | $ | 2,091,943 |
For
the Three Months Ended March 31,
|
||||||||
(Restated - See Note 6)
|
||||||||
2009
|
2008
|
|||||||
CONTRACT
REVENUES
|
$ | 1,054,702 | $ | 1,526,602 | ||||
COST
OF SALES
|
818,893 | 1,308,479 | ||||||
GROSS
PROFIT
|
235,809 | 218,123 | ||||||
OPERATING
EXPENSES
|
||||||||
Consulting
and other compensation
|
62,615 | 271,384 | ||||||
Salaries
and related
|
153,087 | 53,496 | ||||||
Selling,
general and administrative
|
232,021 | 438,029 | ||||||
TOTAL
OPERATING EXPENSES
|
447,723 | 762,909 | ||||||
OPERATING
LOSS
|
(211,914 | ) | (544,786 | ) | ||||
OTHER
INCOME (EXPENSES)
|
||||||||
Gain
on writeoff of accounts payable
|
5,681 | 56,628 | ||||||
(Loss)
/ gain on valuation of derivative liabilities
|
(1,800,978 | ) | 1,300,762 | |||||
Interest
expense
|
(668,395 | ) | (486,769 | ) | ||||
TOTAL
OTHER INCOME (EXPENSES)
|
(2,463,692 | ) | 870,621 | |||||
INCOME
(LOSS) BEFORE PROVISION FOR INCOME TAXES
|
(2,675,606 | ) | 325,835 | |||||
PROVISION
FOR INCOME TAXES
|
- | - | ||||||
NET
INCOME ( LOSS)
|
$ | (2,675,606 | ) | $ | 325,835 | |||
NET
INCOME (LOSS) APPLICABLE TO COMMON STOCKHOLDERS
|
$ | (2,675,606 | ) | $ | 325,835 | |||
Basic
net income (loss) available to common stockholders per common
share
|
$ | (0.17 | ) | $ | 0.02 | |||
Diluted
net income (loss) available to common stockholders per common
share
|
$ | (0.17 | ) | $ | 0.01 | |||
Basic
weighted average common shares outstanding
|
15,344,654 | 14,033,089 | ||||||
Diluted
weighted average common shares outstanding
|
15,344,654 | 41,981,711 |
(Restated - See Note 6)
|
||||||||
2009
|
2008
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
(loss) income
|
$ | (2,675,606 | ) | $ | 325,835 | |||
Adjustments
to reconcile net (loss) income to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization of property and equipment
|
14,030 | 20,757 | ||||||
Gain
on write off of accounts payable
|
(5,681 | ) | (56,628 | ) | ||||
Amortization
of deferred financing costs
|
116,271 | 89,574 | ||||||
Amortization
of stock-based consulting fees and employee compensation
|
20,000 | 125,343 | ||||||
Amortization
of BCF and debt discount
|
508,044 | 251,894 | ||||||
Estimated
fair value of common stock issued for services
|
- | 75,000 | ||||||
(Gain)
/ loss on valuation of derivatives liabilities
|
1,800,978 | (1,300,962 | ) | |||||
Changes
in operating assets and liabilities:
|
||||||||
Contracts
receivable
|
(96,604 | ) | (60,178 | ) | ||||
Inventories
|
151,133 | 170,900 | ||||||
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
314,636 | (22,635 | ) | |||||
Prepaid
expenses and other current assets
|
2,735 | (222,867 | ) | |||||
Accounts
payable and accrued liabilities
|
157,388 | (94,354 | ) | |||||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
(781,287 | ) | 410,089 | |||||
Net
cash used in operating activities
|
(473,963 | ) | (288,232 | ) | ||||
Cash
flows from financing activities:
|
||||||||
Bank
overdraft
|
16,823 | 12,699 | ||||||
Proceeds
from issuance of convertible notes payable, net of financing
costs
|
700,000 | - | ||||||
Principal
payments on notes payable and capital lease
|
(6,654 | ) | (6,196 | ) | ||||
Net
cash provided by financing activities
|
710,169 | 6,503 | ||||||
Net
change in cash
|
236,206 | (281,729 | ) | |||||
Cash
at beginning of period
|
31,889 | 281,729 | ||||||
Cash
at end of period
|
$ | 268,095 | $ | - | ||||
Supplemental
disclosure of non-cash financing and investing activities:
|
||||||||
Debt
discount recorded on convertible notes payable
|
$ | 479,752 | $ | 923,610 |
·
|
The
Company continues its aggressive program for selling
machines.
|
·
|
The Company continues to
implement plans to further reduce operating
costs.
|
·
|
The Company is seeking investment
capital through the public and private
markets.
|
·
|
The Company is seeking strategic
acquisition candidates.
|
|
Weighted
|
|||||||||||||||
|
Weighted
|
Average
|
||||||||||||||
|
Average
|
Remaining
|
Aggregate
|
|||||||||||||
|
Number of
|
Exercise
|
Contractual
|
Intrinsic
|
||||||||||||
|
Shares
|
Price
|
Term in Years
|
Value (1)
|
||||||||||||
|
||||||||||||||||
Vested
|
3,450,000
|
$
|
0.17
|
1.74
|
$
|
—
|
||||||||||
Expected
to vest (2)
|
650,000
|
$
|
0.08
|
0.16
|
$
|
—
|
||||||||||
Total
|
4,100,000
|
|
$
|
—
|
(1)
|
Represents
the added value as difference between the exercise price and the closing
market price of the Company's common stock at the end of the reporting
period (as of March 31, 2009 and December 31, 2008, the market price of
the Company's common stock was $0.08 and $0.05,
respectively).
|
(2)
|
The
650,000 options became fully vested on April 8, 2009 and are valued at
$35,014 based on the stock market price of the shares at the contract
date.
|
Exercise Price
|
|
Number of
Options
outstanding
|
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
|
Weighted
Average
Exercise
Price
|
|
||||
$
0.075-0.083
|
1,300,000
|
0.32
|
$
|
0.08
|
|||||||||
$
0.15-0.20
|
2,800,000
|
1.42
|
$
|
0.19
|
|||||||||
4,100,000
|
$
|
0.15
|
|
Outstanding Warrants
|
|||||||||||
|
Weighted
|
Aggregate
|
||||||||||
|
Number of
|
Average
|
Intrinsic
|
|||||||||
|
Shares
|
Exercise Price
|
Value (1)
|
|||||||||
December
31, 2008
|
5,586,824
|
$
|
0.21
|
$
|
—
|
|||||||
Grants
|
—
|
—
|
||||||||||
—
|
—
|
|||||||||||
Exercises
|
—
|
—
|
||||||||||
Cancellations/
Terminated
|
—
|
—
|
—
|
|||||||||
Outstanding
and Exercisable at
|
||||||||||||
March
31, 2009
|
5,586,824
|
$
|
0.21
|
—
|
|
(1)
|
Represents
the added value as difference between the exercise price and the closing
market price of the Company's common stock at the end of the reporting
period (as of March 31, 2009 and December 31, 2008, the market price of
the Company's common stock was $0.08 and $0.05,
respectively).
|
Exercise Price
|
Number of
Warrants
outstanding
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
Weighted
Average
Exercise
Price
|
||||||||||
$
0.60-0.70
|
1,372,538
|
0.78
|
$
|
0.64
|
|||||||||
$
0.07
|
4,214,286
|
3.58
|
$
|
0.07
|
|||||||||
5,586,824
|
$
|
0.21
|
|
March 31,
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
2009
|
||||||||||||
Fair
Value of derivative liability
|
— | $ | — | $ | 4,306,028 | $ | 4,306,028 |
Derivative
liability - December 31, 2008
|
$
|
2,025,298
|
||
Derivative
liability added during the year
|
479,752
|
|||
Increase
in fair value of derivative liability
|
1,800,978
|
|||
Total
derivative liability - March 31, 2009
|
$
|
4,306,028
|
|
(Restated)
March
31, 2009
|
December 31, 2008
|
||||||
Cumulative
costs to date
|
$
|
2,029,000
|
$
|
6,756,000
|
||||
Cumulative
gross profit to date
|
1,547,000
|
5,768,000
|
||||||
Cumulative
revenue earned
|
3,576,000
|
12,524,000
|
||||||
Less
progress billings to date
|
(4,081,000
|
)
|
(13,495,000
|
)
|
||||
Net
over billings
|
$
|
(505,000
|
)
|
$
|
(971,000
|
)
|
|
(Restated)
March
31, 2009
|
December 31, 2008
|
||||||
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
$
|
102,000
|
$
|
417,000
|
||||
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
(607,000
|
)
|
(1,388,000
|
)
|
||||
Net
over billings
|
$
|
(505,000
|
)
|
$
|
(971,000
|
)
|
|
(Restated)
March
31, 2009
|
December 31, 2008
|
||||||||||||||
CONV NOTES
|
CAMOFI
|
CAMHZN
|
CAMOFI
|
CAMHZN
|
||||||||||||
Principal
|
$
|
2,827,281
|
$
|
750,000
|
$
|
2,827,281
|
$
|
750,000
|
||||||||
Discount
related to warrants liability
|
(100,355
|
)
|
(41,170
|
)
|
(119,369
|
)
|
(48,890
|
)
|
||||||||
Discount
related to convertible option liability
|
(1,605,749
|
)
|
(253,643
|
)
|
(1,909,996
|
)
|
(301,200
|
)
|
||||||||
Discount
related to stock issued with notes
|
(50,508
|
)
|
(60,078
|
)
|
||||||||||||
Notes
presented net of debt discounts
|
$
|
1,070,669
|
$
|
455,187
|
$
|
737,838
|
$
|
399,910
|
||||||||
Accrued
Interest
|
$
|
141,364
|
$
|
65,626
|
$
|
56,546
|
$
|
37,500
|
Three months ended March
31, 2008
|
||||||||||||
Per Share
|
||||||||||||
Income
|
Shares
|
Amount
|
||||||||||
Net
income
|
$
|
325,835
|
||||||||||
Less:
Preferred stock dividends
|
-
|
|||||||||||
Basic
income available to common shareholders
|
$
|
325,835
|
14,033,089
|
$
|
0.02
|
|||||||
Add:
Preferred dividends
|
-
|
|||||||||||
Add:
Interest on convertible debt
|
254,100
|
-
|
||||||||||
Add:
Dilutive impact of convertible preferred stock
|
-
|
1,026,676
|
||||||||||
Add:
Dilutive impact of convertible debt
|
-
|
23,333,333
|
||||||||||
Add:
Dilutive impact of options and warrants
|
-
|
3,588,614
|
||||||||||
Diluted
income available to common shareholders
|
$
|
579,935
|
41,981,711
|
$
|
0.01
|
Effect of Correction
|
As Previously Reported
|
Adjustment
|
As Restated
|
|||||||||
Balance
Sheet as of March 31, 2008
|
||||||||||||
Conversion
Option Liability
|
-
|
2,737,709
|
2,737,709
|
|||||||||
Warrant
Liability
|
-
|
1,713,023
|
1,713,023
|
|||||||||
Accumulated
Deficit
|
12,207,494
|
2,445,694
|
14,653,188
|
|||||||||
Total
Stockholders’ Deficit (equity)
|
1,908,610
|
4,651,075
|
6,559,685
|
|||||||||
Statement
of Operations for the three months ended March 31, 2008
|
||||||||||||
Marked-to-Market
Gain (Loss)
|
-
|
1,300,762
|
1,300,762
|
|||||||||
Net
Income (Loss)
|
(974,927
|
)
|
1,300,762
|
325,835
|
||||||||
Net
Income (Loss) Available to common shareholders
|
(974,927
|
)
|
1,300,762
|
325,835
|
||||||||
EPS
- Basic
|
(0.07
|
)
|
0.09
|
0.02
|
||||||||
EPS
- Diluted
|
(0.07
|
)
|
0.08
|
0.01
|
Effect of Correction
|
As Previously Reported
|
Adjustment
|
As Restated
|
|||||||||
Balance
Sheet as of March 31, 2009
|
||||||||||||
(1)
Costs in Excess of Billings
|
15,551 | 86,477 | 102,028 | |||||||||
(2)
Deferred financing costs
|
435,986 | 108,750 | 544,736 | |||||||||
(3)
Accounts payable and accrued liabilities
|
1,625,005 | 105,834 | 1,519,171 | |||||||||
(4)
Billings in Excess of Costs
|
823,478 | (216,417 | ) | 607,061 | ||||||||
(5)
February 2009 Convertible Notes
|
564,984 | 49,801 | 515,183 | |||||||||
(6)
Derivative Liability
|
4,885,000 | (578,972 | ) | 4,306,028 | ||||||||
(7)Accumulated
Deficit
|
16,701,824 | (1,146,263 | ) | 15,555,561 | ||||||||
Statement
of Operations for the three months ended March 31, 2009
|
||||||||||||
(8)
Sales
|
1,298,458 | (243,756 | ) | 1,054,702 | ||||||||
(9)
Cost of sales
|
1,365,543 | (546,650 | ) | 818,893 | ||||||||
(10)
Selling, general and administrative
|
268,271 | (36,250 | ) | 232,021 | ||||||||
(11)
Marked-to-Market Gain (Loss)
|
(2,738,436 | ) | 937,458 | (1,800,978 | ) | |||||||
(12)
Interest expense
|
(490,498 | ) | (177,897 | ) | (668,395 | ) | ||||||
(13)
Net Loss
|
(3,821,869 | ) | 1,146,263 | (2,675,606 | ) | |||||||
Net
Loss Available to common shareholders
|
(3,821,869 | ) | 1,146,263 | (2,675,606 | ) | |||||||
EPS
– Basic
|
(0.25 | ) | 0.08 | (0.17 | ) | |||||||
EPS
- Diluted
|
(0.25 | ) | 0.08 | (0.17 | ) |
(1)
|
Adjustment in order to reconcile
the Company’s balance sheet account to the Company’s contract accounting
worksheets.
|
(2)
|
Represents the reclassification
of $145,000 of financing costs in connection with the February 2009 notes,
less amortization of
$36,250.
|
(3)
|
Adjustment primarily reflects a
classification error of $80,000 related to derivative
liabilities.
|
(4)
|
Adjustment in order to reconcile
the Company’s balance sheet account to the Company’s contract accounting
worksheets.
|
(5)
|
Adjustment reflects an increase
of $278,486 of debt discount related to the valuation of the conversion
options and an increase of $119,935 of amortization of such options, net
of reclassification of financing costs of $108,750 noted in (2)
above.
|
(6)
|
Adjustment reflects an increase
of $278,486 related to the valuation of the conversion options of the
February 2009 notes and a decrease in the loss on fair value of $937,458
and corrections of $80,000 of misclassifications between the change in
fair value and interest
expense.
|
(7)
|
and (13) The cumulative effect of
adjustments (8) through
(12).
|
(8)
|
and (9) Adjustment in order to
reconcile the Company’s P&L accounts to the Company’s contract
accounting worksheets.
|
(10)
|
Adjustment relates to the
reclassification of deferred financing costs to interest
expense.
|
(11)
|
Adjustment primarily relates to
an increase of $278,486 in the original valuation of the conversion
options in connection with the February 2009 notes, misclassification of
derivative liabilities noted in (3) above and an overall decrease in the
valuation of all derivatives of
$578,972.
|
(12)
|
Adjustment relates to proper
classification and recording of interest
expense.
|
Increase/(Decrease)
%
|
||||
Consulting and other compensation
|
(77 | ) | ||
Salaries and related
|
186 | |||
Selling, general and administrative
|
(57 | ) |
|
·
|
The controls identified in the
process documentation were not designed effectively and had no evidence of
operating effectiveness for testing
purposes.
|
|
·
|
The controls identified in the
process documentation did not cover all the risks for the specific
process
|
|
·
|
The controls identified in the
process documentation did not cover all applicable assertions for the
significant accounts.
|
August
28, 2009
|
NEW CENTURY COMPANIES,
INC.
|
/s/
DAVID DUQUETTE
|
|
Name: David
Duquette
|
|
Title:
Chairman, President and
Director
|
August
28, 2009
|
/s/ DAVID DUQUETTE
|
Name: David
Duquette
|
|
Title:
Chairman, President and Director
|
|
August
28, 2009
|
/s/ JOSEF CZIKMANTORI
|
Name:
Josef Czikmantori
|
|
Title:
Secretary and Director
|